Advertisement
Prior to joining the Medical Capital Development team, Mr. O'Donnell ledthe global marketing organization for biomaterial medical device start-upcompany Confluent Surgical, Inc. While at Confluent Surgical, Mr. O'Donnellwas responsible for the global launch of the organization's flagship hydrogeltechnology, DuraSeal(TM), into the neurosurgical market through an independentsales network. Mr. O'Donnell was also responsible for building thetechnology's value in spine, thoracic, and vascular markets. In 2007, Mr.O'Donnell played a participatory role in the $245 million acquisition andsubsequent integration of Confluent Surgical by Tyco Healthcare, now Covidien.
Advertisement
Prior to Confluent Surgical, Mr. O'Donnell spent 13 years in the spine,orthobiologics, and orthopaedics industry at Johnson & Johnson's DePuy Spineprimarily in sales, sales management and marketing capacities.
Mr. O'Donnell received his B.A. degree from the University of Wisconsin-Madison and his addition to the multidisciplinary team further strengthensMedical Capital Advisors position as a leader in the medical technologyindustry.
About Medical Capital Group
Medical Capital Group is a healthcare merchant banking firm providingstrategic and investment banking services and financing to leading medicaltechnology and healthcare companies. Through deep domain expertise and amulti-disciplinary team approach, MedCap delivers a paramount level of marketinsight and client service to firms who wish to access capital through merger,acquisition, private equity/venture capital financing, or strategicpartnerships. For more information on Curative Biosciences or Mobius MedicalHolding & Distribution Company, please visit http://www.medcapadvisors.com orcall (781) 839-7364.
SOURCE Medical Capital Group
